Methods for diagnosing RCC and other solid tumors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 3, 2009
Grant Date -
Jun 10, 2004
app pub date -
Nov 21, 2003
filing date -
Nov 21, 2002
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Methods, systems and equipment for diagnosing renal cell carcinoma (RCC) and other solid tumors. This invention identifies numerous disease genes that are differentially expressed in the peripheral blood of patients having RCC or other solid tumors relative to disease-free humans. These disease genes can be used as surrogate markers for detecting the presence or absence of RCC or other solid tumors.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully